Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

A. Gordon Robertson; Clarice S. Groeneveld; Brian Jordan; Xiaoqi Lin; Kimberly A. McLaughlin; Arighno Das; Leigh Ann Fall; Damiano Fantini; Timothy J. Taxter; Lauren S. Mogil; Sia Viborg Lindskrog; Lars Dyrskjøt; David J. McConkey; Robert S. Svatek; Aurélien de Reyniès; Mauro A.A. Castro; Joshua J. Meeks

doi:10.1016/j.eururo.2021.11.001

Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, Xiaoqi Lin, Kimberly A. McLaughlin, Arighno Das, Leigh Ann Fall, Damiano Fantini, Timothy J. Taxter, Lauren S. Mogil, Sia Viborg Lindskrog, Lars Dyrskjøt, David J. McConkey, Robert S. Svatek, Aurélien de Reyniès, Mauro A.A. Castro, Joshua J. Meeks

Department of Urology

Resultado de la investigación: Comment/debate › revisión exhaustiva

Resumen

In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.

Idioma original	English (US)
Páginas (desde-hasta)	e53
Publicación	European Urology
Volumen	81
N.º	2
DOI	https://doi.org/10.1016/j.eururo.2021.11.001
Estado	Published - feb 2022

ASJC Scopus subject areas

Urology

Acceder al documento

10.1016/j.eururo.2021.11.001

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))'. En conjunto forman una huella única.

Citar esto

Robertson, A. G., Groeneveld, C. S., Jordan, B., Lin, X., McLaughlin, K. A., Das, A., Fall, L. A., Fantini, D., Taxter, T. J., Mogil, L. S., Lindskrog, S. V., Dyrskjøt, L., McConkey, D. J., Svatek, R. S., de Reyniès, A., Castro, M. A. A., & Meeks, J. J. (2022). Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048)). European Urology, 81(2), e53. https://doi.org/10.1016/j.eururo.2021.11.001

Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048)). / Robertson, A. Gordon; Groeneveld, Clarice S.; Jordan, Brian et al.

En: European Urology, Vol. 81, N.º 2, 02.2022, p. e53.

Resultado de la investigación: Comment/debate › revisión exhaustiva

Robertson, AG, Groeneveld, CS, Jordan, B, Lin, X, McLaughlin, KA, Das, A, Fall, LA, Fantini, D, Taxter, TJ, Mogil, LS, Lindskrog, SV, Dyrskjøt, L, McConkey, DJ, Svatek, RS, de Reyniès, A, Castro, MAA & Meeks, JJ 2022, 'Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))', European Urology, vol. 81, n.º 2, pp. e53. https://doi.org/10.1016/j.eururo.2021.11.001

@article{25633a84eea04d3ba6aaa87092685cfb,

title = "Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))",

abstract = "In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.",

author = "Robertson, {A. Gordon} and Groeneveld, {Clarice S.} and Brian Jordan and Xiaoqi Lin and McLaughlin, {Kimberly A.} and Arighno Das and Fall, {Leigh Ann} and Damiano Fantini and Taxter, {Timothy J.} and Mogil, {Lauren S.} and Lindskrog, {Sia Viborg} and Lars Dyrskj{\o}t and McConkey, {David J.} and Svatek, {Robert S.} and {de Reyni{\`e}s}, Aur{\'e}lien and Castro, {Mauro A.A.} and Meeks, {Joshua J.}",

note = "Publisher Copyright: {\textcopyright} 2021",

year = "2022",

month = feb,

doi = "10.1016/j.eururo.2021.11.001",

language = "English (US)",

volume = "81",

pages = "e53",

journal = "European Urology",

issn = "0302-2838",

publisher = "Elsevier",

number = "2",

}

TY - JOUR

T1 - Corrigendum to “Identification of Differential Tumor Subtypes of T1 Bladder Cancer” [Eur. Urol. 78 (2020) 533–537] (European Urology (2020) 78(4) (533–537), (S030228382030508X), (10.1016/j.eururo.2020.06.048))

AU - Robertson, A. Gordon

AU - Groeneveld, Clarice S.

AU - Jordan, Brian

AU - Lin, Xiaoqi

AU - McLaughlin, Kimberly A.

AU - Das, Arighno

AU - Fall, Leigh Ann

AU - Fantini, Damiano

AU - Taxter, Timothy J.

AU - Mogil, Lauren S.

AU - Lindskrog, Sia Viborg

AU - Dyrskjøt, Lars

AU - McConkey, David J.

AU - Svatek, Robert S.

AU - de Reyniès, Aurélien

AU - Castro, Mauro A.A.

AU - Meeks, Joshua J.

PY - 2022/2

Y1 - 2022/2

N2 - In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.

AB - In the original article, the name of author Xiaoqi Lin was incorrectly given as Xiquo Lin. Conflicts of interest: Joshua J. Meeks is a consultant for Ferring, AstraZeneca, and Janssen and has participated in advisory boards for Foundation Medicine and Nucleix. The remaining authors have nothing to disclose.

UR - http://www.scopus.com/inward/record.url?scp=85120991663&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85120991663&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2021.11.001

DO - 10.1016/j.eururo.2021.11.001

M3 - Comment/debate

C2 - 34801336

AN - SCOPUS:85120991663

SN - 0302-2838

VL - 81

SP - e53

JO - European Urology

JF - European Urology

IS - 2

ER -